Skip to main content

Table 1 Patient demographics, immunosuppressive treatments and disease characteristics at the time of interview

From: Cross sectional, qualitative thematic analysis of patient perspectives of disease impact in juvenile idiopathic arthritis-associated uveitis

Gender

Age (years)

Diagnosis

Duration of arthritis / uveitis (years)

Previous treatment

Treatment at time of interview

Active joints

Uveitis complications

Ophthalmic surgery

Eye

Visual acuity (LogMAR)

Anterior chamber cells (SUN grade)

M

6

Extended oligo JIA

Left anterior uveitis

6 / 3.5

TS, MTX sc, ETA (stopped after onset of uveitis), ADA

MTX sc, ADA

nil

Posterior synechiae, cataract, band keratopathy

Orbital floor steroid injection

RE

0.000

0

LE

0.150

0.5

F

7

RF-ve poly JIA

Bilateral anterior uveitis

5 / 1.5

TS, MTX sc

MTX sc, ADA

nil

Glaucoma

Nil

RE

0.000

0

LE

0.050

0

F

7

Persistent oligo JIA

Bilateral anterior uveitis

2 / 2

TS, MTX sc

TS, MTX sc

nil

nil

nil

RE

−0.100

0

LE

−0.100

0

F

10

Extended oligo JIA

Bilateral anterior uveitis

5 / 5

TS, IVMP, MTX, MMF, INF, ADA

TS, MMF, ADA

nil

Posterior synechiae cataract, glaucoma

Cataract surgery BE, glaucoma surgery BE

RE

0.075

0

LE

0.025

0.5

F

10

RF-ve poly JIA

Bilateral anterior uveitis

9 / 5

TS, MTX sc, IVMP, INF, MMF, ADA

TS, MTX sc, ADA

Left ankle

Posterior synechiae, cataract, glaucoma, CMO, band keratopathy

Cataract surgery BE, Trabeculectomy BE

RE

0.125

0.5

LE

0.175

0.5

M

13

RF-ve poly JIA

Bilateral anterior uveitis

>8 / 6

IVMP, INF, MTX sc, ADA, MMF, ABA

MTX, MMF, ABA

nil

Posterior synechiae, cataract

Cataract surgery RE

RE

0.050

2

LE

−0.100

3

F

14

Extended oligo JIA

Bilateral anterior uveitis

>8 / >8

TS, MTX sc, INF

TS, MTX sc, ADA

Left hip, right knee

Cataract, glaucoma

Cataract surgery BE, glaucoma surgery BE

RE

−0.100

0.5

LE

HM

0.5

M

16

Blau syndrome

Bilateral panuveitis

15 / 8

TS, MTX sc, ADA

TS, MTX sc, MMF, IVMP, INF

nil

Posterior synechiae, cataract, chorioretinal scars, vitritis

nil

RE

0.850

1

LE

0.100

1

M

16

Psoriatic JIA

Bilateral anterior uveitis

>8 / >8

MTX sc, INF

MTX sc, ADA

nil

nil

nil

RE

0.000

0

LE

−0.075

0

M

17

Extended oligo JIA

Bilateral panuveitis

9 / 8

TS, MTX sc

TS, MTX sc

nil

Cataract, glaucoma

ST steroid injection RE

RE

0.125

0.5

LE

−0.200

2

  1. Legend: ABA Abatacept, ADA Adalimumab, BE Both eyes, CMO, Cystoid macular oedema, ETA Etanercept, HM Hand motion, INF Infliximab, IVMP Intravenous methylprednisolone, JIA Juvenile idiopathic arthritis, LE Left eye, MMF Mycophenolate mofetil, MTX Methotrexate, oligo Oligoarticular, poly Polyarticular, RE Right eye, RF Rheumatoid factor, sc Subcutaneously, ST Sub-Tenon’s capsule, SUN Standardisation of Uveitis Nomenclature, TS Topical steroids